Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$4,050,059
+$91,109 QoQ
Shares Held
15,947
-1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#1,765
of 4,676 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILDRESS CAPITAL ADVISORS, LLC holds $17,780,353 across 10 Drug Manufacturers - General names. JNJ ranks #1 (22.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
15,947 | $4,050,059 | |
| 2 | LLY |
ELI LILLY & Co
|
3,245 | $3,892,150 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,037 | $2,703,254 | |
| 4 | ABBV |
AbbVie Inc.
|
9,282 | $2,335,722 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,874 | $1,752,841 | |
| 6 | AMGN |
Amgen Inc
|
3,488 | $1,263,074 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,974 | $747,561 | |
| 8 | PFE |
Pfizer Inc
|
21,776 | $524,366 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,050,059 | 15,947 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $3,958,950 | 16,196 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $3,417,158 | 16,512 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,803,364 | 15,119 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,986,361 | 13,004 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,647,122 | 9,932 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,378,807 | 9,534 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,582,677 | 9,766 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,404,012 | 9,606 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,687,096 | 10,665 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,647,494 | 10,511 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $1,974,442 | 12,677 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $668,700 | 4,040 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $626,200 | 4,040 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,414,452 | 13,668 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,199,805 | 13,466 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $2,388,219 | 13,454 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,182,055 | 12,312 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,006,137 | 11,727 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,418,616 | 8,784 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,407,703 | 8,545 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $1,416,697 | 8,620 | Shares | Sole | 2021-05-21 | |
| 2020-12-31 | $753,220 | 4,786 | Shares | Sole | 2021-03-09 | |
| No filing history on record for this holder in this stock. | ||||||